McDonald’s Corp. has finally updated its antibiotics policy that calls for reduced antibiotic usage after a two-year delay.
The fast-food giant’s new policy revealed in Decemebr follows guidelines set out by the World Health Organization (WHO), the World Organization for Animal Health, and other public and animal health groups.
According to McDonald’s, they will focus on the responsible use of medically important antibiotics and be aligned with WHO Guidelines on Antimicrobial Resistance.
The company added that its policy does not permit the routine use of medically important antibiotics for growth promotion or tdisease prevention.
It is committed to usage reduction, where possible without adverse effects on animal health and welfare.
The company has established market-specific targets for the responsible use of antibiotics for 10 in-scope markets, representing over 80 percent of its global beef supply chain.
In 2023, McDonald’s plans to share an update on its antibiotic usage.
However, the Natural Resources Defense Council (NRDC) criticized McDonald’s for failing to detail a rollout plan or a completion date to ensure accountability across the supply chain.
According to Lena Brook, director of food campaigns at NRDC, it is especially disappointing given that McDonald’s, the world’s largest beef buyer, chose optics over substance with its new beef policy update despite the urgency of the global antibiotic resistance crisis.
McDonald’s earned a grade of C from the NDRC for its previous policy. NDRC called McDonald’s updated policy a “new, weaker approach.”


Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
Australia’s December Trade Surplus Expands but Falls Short of Expectations
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Instagram Outage Disrupts Thousands of U.S. Users
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 



